Copyright Reports & Markets. All rights reserved.

Global NGS-based RNA-seq Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of NGS-based RNA-seq

      • 1.1 Definition of NGS-based RNA-seq
      • 1.2 NGS-based RNA-seq Segment by Type
        • 1.2.1 Global NGS-based RNA-seq Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 SBS
        • 1.2.3 SMRT
      • 1.3 NGS-based RNA-seq Segment by Applications
        • 1.3.1 Global NGS-based RNA-seq Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Transcriptome Epigenetics
        • 1.3.3 Small RNA
      • 1.4 Global NGS-based RNA-seq Overall Market
        • 1.4.1 Global NGS-based RNA-seq Revenue (2014-2025)
        • 1.4.2 Global NGS-based RNA-seq Production (2014-2025)
        • 1.4.3 North America NGS-based RNA-seq Status and Prospect (2014-2025)
        • 1.4.4 Europe NGS-based RNA-seq Status and Prospect (2014-2025)
        • 1.4.5 China NGS-based RNA-seq Status and Prospect (2014-2025)
        • 1.4.6 Japan NGS-based RNA-seq Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia NGS-based RNA-seq Status and Prospect (2014-2025)
        • 1.4.8 India NGS-based RNA-seq Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of NGS-based RNA-seq
      • 2.3 Manufacturing Process Analysis of NGS-based RNA-seq
      • 2.4 Industry Chain Structure of NGS-based RNA-seq

      3 Development and Manufacturing Plants Analysis of NGS-based RNA-seq

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global NGS-based RNA-seq Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of NGS-based RNA-seq
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 NGS-based RNA-seq Production and Capacity Analysis
      • 4.2 NGS-based RNA-seq Revenue Analysis
      • 4.3 NGS-based RNA-seq Price Analysis
      • 4.4 Market Concentration Degree

      5 NGS-based RNA-seq Regional Market Analysis

      • 5.1 NGS-based RNA-seq Production by Regions
        • 5.1.1 Global NGS-based RNA-seq Production by Regions
        • 5.1.2 Global NGS-based RNA-seq Revenue by Regions
      • 5.2 NGS-based RNA-seq Consumption by Regions
      • 5.3 North America NGS-based RNA-seq Market Analysis
        • 5.3.1 North America NGS-based RNA-seq Production
        • 5.3.2 North America NGS-based RNA-seq Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America NGS-based RNA-seq Import and Export
      • 5.4 Europe NGS-based RNA-seq Market Analysis
        • 5.4.1 Europe NGS-based RNA-seq Production
        • 5.4.2 Europe NGS-based RNA-seq Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe NGS-based RNA-seq Import and Export
      • 5.5 China NGS-based RNA-seq Market Analysis
        • 5.5.1 China NGS-based RNA-seq Production
        • 5.5.2 China NGS-based RNA-seq Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China NGS-based RNA-seq Import and Export
      • 5.6 Japan NGS-based RNA-seq Market Analysis
        • 5.6.1 Japan NGS-based RNA-seq Production
        • 5.6.2 Japan NGS-based RNA-seq Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan NGS-based RNA-seq Import and Export
      • 5.7 Southeast Asia NGS-based RNA-seq Market Analysis
        • 5.7.1 Southeast Asia NGS-based RNA-seq Production
        • 5.7.2 Southeast Asia NGS-based RNA-seq Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia NGS-based RNA-seq Import and Export
      • 5.8 India NGS-based RNA-seq Market Analysis
        • 5.8.1 India NGS-based RNA-seq Production
        • 5.8.2 India NGS-based RNA-seq Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India NGS-based RNA-seq Import and Export

      6 NGS-based RNA-seq Segment Market Analysis (by Type)

      • 6.1 Global NGS-based RNA-seq Production by Type
      • 6.2 Global NGS-based RNA-seq Revenue by Type
      • 6.3 NGS-based RNA-seq Price by Type

      7 NGS-based RNA-seq Segment Market Analysis (by Application)

      • 7.1 Global NGS-based RNA-seq Consumption by Application
      • 7.2 Global NGS-based RNA-seq Consumption Market Share by Application (2014-2019)

      8 NGS-based RNA-seq Major Manufacturers Analysis

      • 8.1 Illumina
        • 8.1.1 Illumina NGS-based RNA-seq Production Sites and Area Served
        • 8.1.2 Illumina Product Introduction, Application and Specification
        • 8.1.3 Illumina NGS-based RNA-seq Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Thermo Fisher Scientific
        • 8.2.1 Thermo Fisher Scientific NGS-based RNA-seq Production Sites and Area Served
        • 8.2.2 Thermo Fisher Scientific Product Introduction, Application and Specification
        • 8.2.3 Thermo Fisher Scientific NGS-based RNA-seq Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Pacific Biosciences Of California
        • 8.3.1 Pacific Biosciences Of California NGS-based RNA-seq Production Sites and Area Served
        • 8.3.2 Pacific Biosciences Of California Product Introduction, Application and Specification
        • 8.3.3 Pacific Biosciences Of California NGS-based RNA-seq Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Qaigen
        • 8.4.1 Qaigen NGS-based RNA-seq Production Sites and Area Served
        • 8.4.2 Qaigen Product Introduction, Application and Specification
        • 8.4.3 Qaigen NGS-based RNA-seq Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 F. Hoffmann-La Roche
        • 8.5.1 F. Hoffmann-La Roche NGS-based RNA-seq Production Sites and Area Served
        • 8.5.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
        • 8.5.3 F. Hoffmann-La Roche NGS-based RNA-seq Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Agilent Technologies
        • 8.6.1 Agilent Technologies NGS-based RNA-seq Production Sites and Area Served
        • 8.6.2 Agilent Technologies Product Introduction, Application and Specification
        • 8.6.3 Agilent Technologies NGS-based RNA-seq Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Oxford Nanopore Technologies
        • 8.7.1 Oxford Nanopore Technologies NGS-based RNA-seq Production Sites and Area Served
        • 8.7.2 Oxford Nanopore Technologies Product Introduction, Application and Specification
        • 8.7.3 Oxford Nanopore Technologies NGS-based RNA-seq Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Perkinelmer
        • 8.8.1 Perkinelmer NGS-based RNA-seq Production Sites and Area Served
        • 8.8.2 Perkinelmer Product Introduction, Application and Specification
        • 8.8.3 Perkinelmer NGS-based RNA-seq Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Eurofins Scientific
        • 8.9.1 Eurofins Scientific NGS-based RNA-seq Production Sites and Area Served
        • 8.9.2 Eurofins Scientific Product Introduction, Application and Specification
        • 8.9.3 Eurofins Scientific NGS-based RNA-seq Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Gatc Biotech
        • 8.10.1 Gatc Biotech NGS-based RNA-seq Production Sites and Area Served
        • 8.10.2 Gatc Biotech Product Introduction, Application and Specification
        • 8.10.3 Gatc Biotech NGS-based RNA-seq Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Macrogen

      9 Development Trend of Analysis of NGS-based RNA-seq Market

      • 9.1 Global NGS-based RNA-seq Market Trend Analysis
        • 9.1.1 Global NGS-based RNA-seq Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 NGS-based RNA-seq Regional Market Trend
        • 9.2.1 North America NGS-based RNA-seq Forecast 2019-2025
        • 9.2.2 Europe NGS-based RNA-seq Forecast 2019-2025
        • 9.2.3 China NGS-based RNA-seq Forecast 2019-2025
        • 9.2.4 Japan NGS-based RNA-seq Forecast 2019-2025
        • 9.2.5 Southeast Asia NGS-based RNA-seq Forecast 2019-2025
        • 9.2.6 India NGS-based RNA-seq Forecast 2019-2025
      • 9.3 NGS-based RNA-seq Market Trend (Product Type)
      • 9.4 NGS-based RNA-seq Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 NGS-based RNA-seq Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market.
        The hospitals and clinics segment is expected to register the highest growth due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics.

        The global NGS-based RNA-seq market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on NGS-based RNA-seq volume and value at global level, regional level and company level. From a global perspective, this report represents overall NGS-based RNA-seq market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of NGS-based RNA-seq in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their NGS-based RNA-seq manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Illumina
        Thermo Fisher Scientific
        Pacific Biosciences Of California
        Qaigen
        F. Hoffmann-La Roche
        Agilent Technologies
        Oxford Nanopore Technologies
        Perkinelmer
        Eurofins Scientific
        Gatc Biotech
        Macrogen

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        SBS
        SMRT

        Segment by Application
        Transcriptome Epigenetics
        Small RNA

        Buy now